NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70000-0263
Requested NDC
70000-0263-01
Package NDCs from labels
70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
Manufacturer
Cardinal Health 110, LLC. dba Leader
Effective date
2025-03-03
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba LeaderCardinal Health 110, LLC. dba Leader2025-03-03HUMAN OTC DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70000-0263-1LEADER CHILDRENS IBUPROFEN1 in 1 CARTONSUSPENSION15
70000-0263-1LEADER CHILDRENS IBUPROFEN120 mL in 1 BOTTLESUSPENSION1205
70000-0263-2LEADER CHILDRENS IBUPROFEN240 mL in 1 BOTTLESUSPENSION2405
70000-0263-2LEADER CHILDRENS IBUPROFEN1 in 1 CARTONSUSPENSION15
70000-0263-3LEADER CHILDRENS IBUPROFEN150 mL in 1 BOTTLESUSPENSION1505
70000-0263-3LEADER CHILDRENS IBUPROFEN1 in 1 CARTONSUSPENSION15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70000-0263LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER]5Current NDC, Legacy NDC, 6 package rows20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70000-0263-1ML - Milliliter70000-0263fbb179f2-5d83-4b39-a4c8-7f816a8d06e212017-11-06
70000-0263-2ML - Milliliter70000-0263fbe88e6f-ef78-4794-b3b0-585c7211eea812017-11-06
70000-0263-3ML - Milliliter70000-02635146b58d-9db9-4309-b673-3ed748b15b8612018-03-08

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 53 of 89 · 1,765 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Dye Free Childrens IbuprofenIBUPROFENCVS2cf2a4de-29d3-8af5-e063-6294a90a9cee2025-05-01WarningsExact identifier
rxcui: 197803
unii: WK2XYI10QM
good sense ibuprofen childrensIBUPROFENL. Perrigo Company6127469c-143f-4dd2-bd37-6630291fcd5a2025-04-30WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
ThroatSprayECHINACEA (ANGUSTIFOLIA), EUGENIA CARYOPHYLLATA, GLYCERINUM, MYRRHA, SALVIA OFFICINALIS, SPILANTHES OLERACEA, THYMUS SERPYLLUM, BAPTISIA TINCTORIA, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, APIS MELLIFICA, BELLADONNA, LACHESIS MUTUS, MERCURIUS SOLUBILIS, HEPAR SULPHURIS CALCAREUMEnergique, Inc.125ffbf4-681e-451c-a96d-0b64166194742025-04-29WarningsExact identifier
unii: PDC6A3C0OX
ibuprofen childrensIBUPROFENCVS Pharmacy4459298c-e0bf-4a10-b68c-6f83fefde7e92025-04-29WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
ibuprofenIBUPROFENH E Bbbcfea51-4c57-4a2c-a0ac-2a189c5ff38a2025-04-28WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
DG Health IbuprofenIBUPROFENDolgencorp Inc0c0cf516-b3e7-474d-885c-897574365be32025-04-28WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
ibuprofen childrensIBUPROFENMeijer Distribution Incc5e1d74d-99a3-4b3d-86c4-03f5c4c22f772025-04-27WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
kirkland signature ibuprofenIBUPROFENCostco Wholesale Company65d8d650-9afc-44f7-9409-a3aa3014d4ab2025-04-24WarningsExact identifier
unii: WK2XYI10QM
ibuprofenIBUPROFENA-S Medication Solutions504c7e5d-e721-4df8-865b-8ea17559831d2025-04-24WarningsExact identifier
unii: WK2XYI10QM
ibuprofen pmDIPHENHYDRAMINE CITRATE, IBUPROFENH E B2114b2a9-f9af-43b9-97ec-859a4afe7ec82025-04-21WarningsExact identifier
unii: WK2XYI10QM
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACIDKesin Pharma Corporation3140f8fe-0644-7561-e063-6394a90a2c282025-04-21Adverse reactionsExact identifier
unii: XF417D3PSL
IbuprofenIBUPROFENAphena Pharma Solutions - Tennessee, LLC334e40f3-6da4-ecbe-e063-6294a90a35bf2025-04-21Boxed warning, Warnings, Adverse reactionsExact identifier
unii: WK2XYI10QM
ADVIL DUAL ACTION WITH ACETAMINOPHENIBUPROFEN, ACETAMINOPHENHaleon US Holdings LLCf5ea858e-76d9-4777-b3dc-5d614f66d4852025-04-21WarningsExact identifier
unii: WK2XYI10QM
good sense ibuprofen pmDIPHENHYDRAMINE CITRATE, IBUPROFENL. Perrigo Company0488786f-9b6b-4935-bb57-bcb2565447f82025-04-21WarningsExact identifier
unii: WK2XYI10QM
Topcare Ibuprofen PMDIPHENHYDRAMINE CITRATE AND IBUPROFENTopco Associates LLC1435e627-144e-4dc8-9ad6-58d91cbd90942025-04-21WarningsExact identifier
unii: WK2XYI10QM
equaline ibuprofen pmDIPHENHYDRAMINE CITRATE, IBUPROFENUnited Natural Foods, Inc. dba UNFI5c4ff82a-bdc4-4df5-9df7-abc6becf4f4d2025-04-21WarningsExact identifier
unii: WK2XYI10QM
Exchange Select Ibuprofen PMDIPHENHYDRAMINE CITRATE, IBUPROFENArmy & Air Force Exchange Service56761c01-48f2-4d17-a607-6639fb3a7a982025-04-21WarningsExact identifier
unii: WK2XYI10QM
Equaline IbuprofenIBUPROFENUnited Natural Foods, Inc. dba UNFI5e860059-afc8-419e-9451-b1c2265f5ce62025-04-18WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
Leader IbuprofenIBUPROFENCardinal Health 110, LLC. dba Leadera5701486-0a5f-4645-91ef-1fbf525c84dd2025-04-18WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM
childrens ibuprofenIBUPROFENMeijer Distribution Inc02681a10-eb8a-457f-8aff-12e6f29079de2025-04-18WarningsExact identifier
application number: ANDA074937
rxcui: 197803
unii: WK2XYI10QM

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.